Advancells Planning to Foray Into B2B Segment - Selling Stem Cells to Pharmaceutical, Research Institutes and Global Research Organizations

Friday, June 8, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NOIDA, India, June 8, 2018 /PRNewswire/ --

Advancellsone of the pioneers in

stem cell research in India, has passionately opened new avenues for therapeutic applications of regenerative medicine that is used in adult stem cells. A 10-crore business, claiming to cure
a variety of diseases including neurological conditions, orthopaedic issues, kidney, liver and lung diseases, cardiology and cosmetic procedures with a team of professionals spread across Noida, Australia and Bangladesh, Advancells might just be one of the biggest facilitator of regenerative medicine .

     (Logo: https://mma.prnewswire.com/media/661237/advancells_Logo.jpg )

The company's biggest strength is manufacturing stem cells, which are used by the startup's partner hospitals and doctors to treat patients. This sector is one of the latest ventures of 41-year-old serial entrepreneur, Vipul Jain, alongside his other businesses.

Even though Advancells has plans to provide each patient a complete solution with a 360-degree management of their disease, it is keen to sell the varied cell lines to pharma companies, research institutes, and global research organizations. In pursuit of this,Advancells has already developed more than 10 different cell lines which can be sold to these organizations, including organ specific cell lines and general human stem cell lines. 

The stem cell regeneration giant is now all set to explore the B2B segment with an aim to become the global leader in providing a viable option for pharma companies to test their product at an initial stage before going into human trials.

One of the major concerns for which the company has chosen to offer the regenerative medicine to pharma companies and research institutes is to replace animal testing in drug development with human cell lines. Advancells has already started supplying cell lines to hospitals and doctors.

Vipul Jain, CEO, Advancells, who firmly believes in statistics, says, "Stem cells have turned out to be a better approach to perform testing, especially given that they can assist us with using less animals in the testing procedure. Even better, they could be much more financially savvy than utilizing animal models of experimentation. By choosing stem cells for surveying drug toxicology, biotechnology and pharmaceutical organizations can quickly test new chemicals and mixes and all the more promptly induce the outcomes to people. This sort of testing would happen very soon in the development protocol."

Vipul Jain, an MBA from Rochester Institute of Technology, New York, and founder of Advancells, describes his vision as "to turn Advancells into the most sought after name in regenerative medicine - not just in India, but across the globe."

"The highlight of this campaign is that it's the newest chapter focused on broadening how people know Advancells by highlighting all the different ways it can reach out to the masses," says Vipul Jain, Founder,Advancells.

About Advancells

Transforming the face of medicine , Advancells was established in the year 2013. Delving in the field of stem cell therapies, the company has been futuristically conceptualist to further modern medicine. Advancells is headquartered in Noida and has representative offices in Bangladesh and Australia. Breaking the stereotype regarding stem cell companies that most often offer arrangements for stem cell banking, this is one of the few organisations in the country that focuses the therapeutic usage of stem cells for a variety of life threatening and life style diseases. Advancells also works on writing protocols for partner doctors and hospitals which they can use for treating the patients using regenerative medicine. Advancells is a GMP compliant research and processing center that works on different cell lines from various sources such as Bone Marrow, Adipose Tissue, Dental Pulp, Blood, Cord Tissue etc. Advancells also intends to file a patent for this processing technology in the near future. Advancells is also associated with 'Champions of Change - Transforming India through G2B partnership' initiative of PM Narendra Modi's government.

Media Contact : Tanvi Garg tanvi.garg@advancells.com +91-9899971296 Senior Relationship Manager, Advancells - Stem Cell Therapies



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store